Comments on: Update Supports Adjuvant Nivolumab as Standard Care in Resected Esophageal or Gastroesophageal Junction Cancer

Comments on: Update Supports Adjuvant Nivolumab as Standard Care in Resected Esophageal or Gastroesophageal Junction Cancer https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/asco-2021/nivolumab-esophageal-cancer-update-standard-care-treatment-risk/ Sun, 06 Jun 2021 14:34:26 +0000 hourly 1 https://wordpress.org/?v=6.4.3